万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生>>康复医学

Oncogenesis(研究方向:肿瘤学医学) (官网投稿)

简介
  • 期刊简称待设置
  • 参考译名待设置
  • 核心类别 外文期刊,
  • IF影响因子待设置
  • 自引率待设置
  • 主要研究方向待设置

主要研究方向:

等待设置主要研究方向
待设置

Oncogenesis出版国家为美国,是一个同行评议的开放获取在线杂志,发表探索癌症和相关现象的分子基础的文章。它致力于促进分子生物学,细胞生物学,肿瘤学和遗传学的多样化和综合领域。
征稿信息

万维提示:

1、投稿方式:在线投稿。

2、期刊官网:

http://www.nature.com/oncsis/index.html

3、期刊投稿:

http://mts-oncsis.nature.com/cgi-bin/main.plex

4、官网邮箱:oncogene@us.nature.com

5、编辑部地址:Nature Publishing Group

One New York Plaza, Suite 4500

New York, NY 10004-1562

6、信息说明:本刊信息来源于网络,包括 SCI 收录核心期刊,增补期刊,期刊收录数据每年进行更新。本站是公益性网站,为网友投稿提供免费服务,由于受相关约束,我们不能提供相关期刊的影响因子、JCR期刊分区等数据供大家参考,造成不便,敬请谅解。

2017222日星期三

                       

 

Instructions for Authors

 

Aims and Scope

Oncogenesis is a peer-reviewed open access online journal that publishes full-length papers exploring the molecular basis of cancer and related phenomena. It seeks to promote diverse and integrated areas of molecular biology, cell biology, oncology, and genetics.

Oncogenesis seeks to encompass the breadth of the molecular biology of malignant change, and topics of particular interest include:

Apoptosis

Cancer metabolism

Cell cycle and growth regulation

Cellular oncogenes

Cellular transformation and immortalization

DNA damage and repair

Mode of action of cancer therapeutics

Molecular oncology

Novel targeted therapies

Senescence

Tumour suppression

Virus-induced oncogenesis

Journal Details

Editor-in-Chief:

Jan Paul Medema

University of Amsterdam, Netherlands

Editorial office:

Nature Publishing Group

One New York Plaza, Suite 4500

New York, NY 10004-1562

oncogene@us.nature.com

ARTICLE TYPE SPECIFICATIONSArticle Description and Word Limit

 

Original Articles (Please see ‘Preparation of Articles’ below for further details)

Manuscripts describing novel experimental findings with more than four figures and/or tables. Keep the text as brief and clear as possible, and prepare figures to occupy a minimum of space.

Full-length papers should not exceed a total of 4,500 words (excluding abstract, references and figure legends). Include the word count for your manuscript in your cover letter.

Reviews

Review articles are summaries of a large field of research. Submissions are typically by Editor invitation only; however, occasionally unsolicited Reviews may be considered. For any inquiries or to propose a Review topic for consideration, please contact the editorial office: oncogene@us.nature.com

Review articles should not exceed 6,000 words.

 

Short Communications

A short communication is a concise, independent report representing a significant and timely contribution to cancer biology. A short communication is not intended to publish preliminary results. The results must be of exceptional interest and relevant to be considered for publication.

The text should be organized with an Introduction, and the Results and Discussion sections should be combined. All Materials and Methods should be included in the figure legends. The text must be succinctly written, and figures (no more than four) prepared to occupy a minimum of space.

Short Communications should not exceed a total of 2,500 words (excluding the abstract, references and legends). Include a word count for your manuscript in your cover letter.

 

Letters to the Editor

Letters to the Editor will be considered for publication, subject to editing. Letters must contain information critical to a certain area or must be confirmatory of data recently published in Oncogenesis.

Letters must reference the original source, and a Response to a Letter must reference the Letter in the first few paragraphs, as well as the original source. Letters can use an arbitrary title, but a Response must cite the title of the Letter: e.g. Response to [title of Letter].

All Letters must contain a title page including all authors’ names and affiliations and corresponding author contact information.

Letters must not exceed 400 words (not including references). There is a limit of five references. The first reference must be the citation for the original article under discussion.

Letters may contain figures or tables (up to two each) only if they show data that refute the original article’s conclusions. Figures or tables showing unpublished data in support of the original article’s conclusions will not be considered.

 

HOW TO SUBMIT

Pre-submission Inquiries

Please submit pre-submission inquiries via the online manuscript submission system or via e-mail to oncogene@us.nature.com.

Online Submission

We only accept manuscript submission via our online manuscript submission system. Before submitting a manuscript, authors are encouraged to consult both our Editorial Policies and the Submission Instructions for our online manuscript submission system. If you have not already done so, please register for an account with our online manuscript system. You will be able to monitor the status of your manuscript online throughout the editorial process.

Submission of Revisions

Authors submitting a revised manuscript after review are asked to include the following:

(1) A letter indicating point-by-point how you have addressed the comments raised by the editors and reviewers. If you disagree with any of the points raised, please provide adequate justification in your letter.

(2) A revised version of the manuscript that includes changes based on the comments raised by the editors and reviewers.

 

编辑委员会

 

主编辑

Jan Paul MedemaLaboratory of Experimental Oncology and RadiobiologyLEXOR),University of AmsterdamNetherlands

 

副主编

Jerry Edward Chipuk,西奈山医学院,纽约,纽约,美国

Greg GoodallSA PathologyAdelaideAustralia

Vincenzo De LaurenziUniversità'G. d'Annunzio'Chieti-Pescara,基耶蒂,意大利

Ricky JohnstonePeter MacCallum癌症中心,澳大利亚维多利亚

James J Manfredi,西奈山医学院,纽约,纽约,美国

Jean-Ehrland RicciINSERMNiceFrance

 

编辑委员会

EH Baehrecke,马萨诸塞州医学院,马萨诸塞州伍斯特市,美国大学

中号Barbacid,炫酷国立科学调查Oncologicas,马德里,西班牙

˚FCECCONI,罗马大学,罗马,意大利

AM Chinnaiyan,密歇根大学安娜堡分校,美国密歇根州

- [R De Maria MarchianoIstituto Superiore diSanità,意大利罗马

G Goodall,澳大利亚阿德莱德癌症生物学中心

Y Gotoh,日本东京东京大学

DR Green,圣犹达儿童研究医院,美国孟菲斯

M Jaattela,大学哥本哈根,哥本哈根,丹麦

摹克勒默,中心德RECHERCHECordoliers,法国巴黎

- [R·库马尔,乔治华盛顿大学,华盛顿特区,美国

- [R沼泽,英国癌症研究中心,伦敦,英国

小号马丁,圣三一学院,都柏林,爱尔兰

- [R Medema,荷兰乌得勒支大学医学中心

G Melino,伦敦医学研究委员会,U

K Miyazono,东京大学,日本东京

C Munoz-PinedoBellvitge生物医学研究所,西班牙巴塞罗那

I Ng,香港大学,中国香港

S Papa,伦敦大学,伦敦,英国

D Pei,广州中国广州生物医学和健康研究所

J Pollack,斯坦福大学,斯坦福大学,美国加利福尼亚州斯坦福

G Semenza,约翰霍普金斯大学,巴尔的摩,

G Stassi,巴勒莫大学,巴勒莫,意大利

S Tait,格拉斯哥大学,英国苏格兰

D TangMD安德森癌症中心,美国

史密斯维尔F Vallette,南特大学,南特,法国

P Vandenabeele,根特大学,根特,比利时

M Wicha,密歇根大学,美国安娜堡

K威尔逊,范德堡大学,纳什维尔,美国

J Yu,香港中文大学,中国香港


投稿问答最小化  关闭